Innovent Biologics Inks Potential 105 Billion Drug Deal with Pfizer MaxLinear Q1 2026 Earnings EPS Beat Sends Mixed Signals as Shares Dip 49 Three Signs from APEC Indicate USChina Trade Rift Persists After TrumpXi Summit